For example, using Bezafibrate, a PGC-1α agonist, has demonstrated enhanced antitumor immunity by upregulating mitochondrial oxidative phosphorylation (OXPHOS) and inhibiting apoptosis in a mouse tumor model (MC38) with PD-1 blockade23. This evidence concerns the gene PDCD1 and neoplasm.